You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoid Malignancy

Showing 1 - 25 of 1,899
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma Trial in Tampa (CC-486, Duvelisib)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 18, 2023

Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

Recruiting
  • Neoplasm, Plasma Cell
  • Lymphoma
  • Comprehensive Geriatric Assessment
  • Toulouse, France
    University Hospital Toulouse
Oct 12, 2022

Natural Killer/T-cell Lymphoma, Relapsed Natural Killer/T-cell Lymphoma, Refractory Natural Killer/T-cell Lymphoma Trial in

Recruiting
  • Natural Killer/T-cell Lymphoma
  • +2 more
  • Seoul, Kangnamgu, Korea, Republic of
    Samsung Medical Center
Sep 22, 2021

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

Recruiting
  • Lymphoid Leukemia, Acute
  • +2 more
  • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
May 24, 2022

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Relapsed Lymphoid Malignancy, Refractory Lymphoid Malignancy Trial in Canada, United States (AGS67E)

Completed
  • Relapsed Lymphoid Malignancy
  • Refractory Lymphoid Malignancy
  • Duarte, California
  • +4 more
Nov 27, 2020

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)

Completed
Has Results
  • Hematologic Malignancy
  • +2 more
  • Positive Psychology Intervention
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Nov 14, 2022

B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

Not yet recruiting
  • B-cell Malignancy
  • +7 more
  • (no location specified)
Oct 26, 2022

Distress Associated With Coronavirus Disease 2019 and Telehealth

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Sep 16, 2022

Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)

Recruiting
  • Hematologic Malignancy
  • +2 more
  • Positive Psychology Intervention
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 20, 2021

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

Enrolling by invitation
  • Monoclonal Gammopathy of Undetermined Significance
  • +6 more
    • Milwaukee, Wisconsin
      Aurora Health Care
    Jul 20, 2021

    Myeloid Hematologic Malignancy, Lymphoid Hematologic Malignancy Trial in New York (Ixazomib)

    Completed
    • Myeloid Hematologic Malignancy
    • Lymphoid Hematologic Malignancy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 3, 2021

    Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

    Recruiting
    • Recurrent Acute Leukemia
    • +16 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

    Terminated
    Has Results
    • Leukemia, Myeloid, Chronic
    • +8 more
    • Stem Cell Transplant
    • +5 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Dec 31, 2020

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Hematologic Malignancy Trial in Palo Alto (Fructooligosaccharide, Laboratory

    Completed
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Recurrent Hematologic Malignancy
    • Fructooligosaccharide
    • Laboratory Biomarker Analysis
    • Palo Alto, California
      Stanford University, School of Medicine
    Mar 18, 2021

    Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor, Type 2 Diabetes Trial in Columbus (Educational Intervention,

    Not yet recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +2 more
    • Educational Intervention
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jun 17, 2021

    MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • +8 more
      • Boston, Massachusetts
      • +6 more
      Apr 14, 2022

      Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ

      Recruiting
      • Acute Lymphoblastic Leukemia, Adult B-Cell
      • +3 more
      • clonoSEQ Assay
      • Stanford, California
      • +15 more
      Jan 30, 2023

      B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose

      Completed
      Has Results
      • B-cell Lymphoma
      • +2 more
      • BI-1206 single agent dose escalation phase
      • +3 more
      • Leicester, England, United Kingdom
      • +4 more
      Jun 17, 2021

      Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

      Completed
      Has Results
      • Adult Nasal Type Extranodal NK/T-cell Lymphoma
      • +18 more
      • Scottsdale, Arizona
      • +1 more
      Sep 28, 2020

      Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Observation
      • (no location specified)
      Oct 12, 2023

      Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

      Recruiting
      • Hematologic Malignancy
      • Myeloid Malignancy
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Nov 7, 2022